Robeco Institutional Asset Management B.V. Increases Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Robeco Institutional Asset Management B.V. increased its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 79.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 103,208 shares of the company's stock after acquiring an additional 45,763 shares during the period. Robeco Institutional Asset Management B.V.'s holdings in GE HealthCare Technologies were worth $8,330,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of GEHC. CoreFirst Bank & Trust bought a new position in shares of GE HealthCare Technologies during the 4th quarter valued at approximately $25,000. Runnymede Capital Advisors Inc. bought a new stake in shares of GE HealthCare Technologies in the 4th quarter worth approximately $28,000. LGT Financial Advisors LLC lifted its stake in GE HealthCare Technologies by 46.2% in the fourth quarter. LGT Financial Advisors LLC now owns 389 shares of the company's stock valued at $30,000 after purchasing an additional 123 shares during the last quarter. Accredited Wealth Management LLC bought a new position in GE HealthCare Technologies during the fourth quarter valued at $30,000. Finally, Ameriflex Group Inc. bought a new position in GE HealthCare Technologies during the fourth quarter valued at $31,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. The Goldman Sachs Group lowered their target price on GE HealthCare Technologies from $94.00 to $82.00 and set a "buy" rating on the stock in a research note on Thursday, May 1st. Citigroup lowered their price objective on GE HealthCare Technologies from $105.00 to $86.00 and set a "buy" rating on the stock in a research note on Wednesday, April 30th. Wells Fargo & Company cut their target price on shares of GE HealthCare Technologies from $103.00 to $89.00 and set an "overweight" rating for the company in a research report on Thursday, May 1st. UBS Group raised shares of GE HealthCare Technologies from a "sell" rating to a "neutral" rating and lowered their price target for the company from $74.00 to $73.00 in a research report on Monday, May 5th. Finally, Evercore ISI dropped their price target on shares of GE HealthCare Technologies from $96.00 to $85.00 and set an "outperform" rating on the stock in a research note on Thursday, May 1st. Three research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of "Moderate Buy" and a consensus price target of $88.27.

GE HealthCare Technologies Price Performance

Shares of GE HealthCare Technologies stock traded up $0.03 on Thursday, reaching $76.15. The stock had a trading volume of 1,800,530 shares, compared to its average volume of 3,507,785. The business's 50 day moving average is $71.38 and its two-hundred day moving average is $77.51. The company has a current ratio of 0.98, a quick ratio of 0.76 and a debt-to-equity ratio of 0.73. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80. The company has a market cap of $34.87 billion, a P/E ratio of 16.03, a price-to-earnings-growth ratio of 2.56 and a beta of 1.14.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Wednesday, April 30th. The company reported $1.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.10. GE HealthCare Technologies had a net margin of 11.02% and a return on equity of 24.95%. The business had revenue of $4.78 billion for the quarter, compared to analysts' expectations of $4.66 billion. During the same period in the prior year, the company posted $0.90 EPS. The business's revenue for the quarter was up 2.7% compared to the same quarter last year. As a group, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies declared that its Board of Directors has authorized a share repurchase program on Wednesday, April 30th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the company to purchase up to 3.1% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company's leadership believes its shares are undervalued.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Investors of record on Friday, July 25th will be paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.18%. GE HealthCare Technologies's dividend payout ratio is 2.95%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.